Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (2308)	12/15/2000 2:01:11 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 52153

I am assuming that the continued fall is due to the suggestion of deliberate manipulation of the data. Really? Is that being suggested? Wouldn't the clinical investigators leap in and claim foul? That seems pretty silly. Every company tries to present their data in best light. The question..... did they deliberately misrepresent communications with FDA regarding liver mets and endpoints? The fact that patients weren't randomized for liver mets would seem telling?